An evaluation of how well tumor cultures grown from cancer patient biopsies called tumor similis and artificial intelligence when used together, identify the most appropriate cancer therapy for cancer patients
Not Applicable
- Registration Number
- CTRI/2024/07/070707
- Lead Sponsor
- VRRX Therapeutics Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Volunteers 18 years of age and older who are being evaluated andor treated for cancer at Paterson Cancer Centre Chennai who have a diagnosed solid tumor through Histopathological analysis
Exclusion Criteria
Volunteers with active andor uncontrolled infections or who are still recovering from a viral or bacterial or fungal infection
Volunteers who are actively febrile patients with uncertain aetiology of febrile episode
Patients who don’t consent for biopsy procedures
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Accrual ceiling achieved for tissue collection and tumor similis culture from accrued tissue Time frame 12 months from initial collection of tissue sample <br/ ><br>Collation of images molecular pathology data and tumor similis treatment response for artificial intelligence objectivesTimepoint: 6 and 12 months from first enrolled patient
- Secondary Outcome Measures
Name Time Method Automated molecular recognition of histopathology verified and correlated with therapy outcomesTimepoint: 12 months;Obtained tumor similis culture data correlated with volunteer therapy outcome dataTimepoint: 12 months;Volunteer therapy outcome data obtained for all tissue collected.Timepoint: 6 and 12 months